Off-label use
Off-label use (cannabis)
Definition:
The term off-label use refers to the use of a medicinal product outside the officially approved indications, dosages or patient groups. In the context of cannabis, this means that cannabis products or extracts are used for medical purposes that are not explicitly approved by the regulatory authorities.
Background:
Cannabis and its active ingredients (such as THC and CBD) are increasingly being used as a treatment option for various diseases. However, many areas of application have not yet been fully researched scientifically or have not yet been recognized by authorities as official indications. Nevertheless, doctors often prescribe cannabis products “off-label” when other therapies are not sufficiently effective or are not tolerated.
Examples of off-label use of cannabis:
- Treatment of chronic pain outside the approved types of pain
- Use for mental illnesses such as anxiety disorders or PTSD (post-traumatic stress disorder)
- Support for neurological diseases such as multiple sclerosis or Parkinson’s disease
- Treatment of loss of appetite or nausea if these are not included in the approved indication
Legal aspects:
Off-label use is generally permitted if a doctor deems it medically necessary. However, the treating doctor is responsible for the benefits and risks. Off-label use is particularly relevant in the case of cannabis, as the approval of cannabis products is restricted in many countries and research is still in its infancy.
Opportunities and risks:
- Opportunities: Possibility to help patients individually when standard therapies fail
- Risks: Lack of studies can lead to uncertainties regarding effect, dosage and side effects; legal and insurance-related uncertainties possible
Conclusion:
The off-label use of cannabis is an important aspect of the medical use of cannabis. It enables flexible treatment, but requires careful consideration and medical expertise in order to achieve the best possible therapeutic success.